Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,135 | 2 | 43.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,450 | 1 | 34.3% |
| Honoraria | $910.00 | 2 | 12.7% |
| Food and Beverage | $413.76 | 15 | 5.8% |
| Education | $244.45 | 2 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,817 | 2 | $0 (2019) |
| Exelixis Inc. | $2,629 | 3 | $0 (2019) |
| Daiichi Sankyo Inc. | $910.00 | 2 | $0 (2023) |
| Incyte Corporation | $355.26 | 2 | $0 (2018) |
| Lilly USA, LLC | $244.45 | 2 | $0 (2018) |
| Janssen Biotech, Inc. | $46.15 | 2 | $0 (2022) |
| Genentech USA, Inc. | $36.42 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $31.12 | 2 | $0 (2023) |
| Global Blood Therapeutics, Inc. | $20.22 | 1 | $0 (2022) |
| Myovant Sciences Inc. | $19.75 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $391.12 | 3 | Daiichi Sankyo Inc. ($360.00) |
| 2022 | $635.00 | 5 | Daiichi Sankyo Inc. ($550.00) |
| 2021 | $16.97 | 1 | Janssen Biotech, Inc. ($16.97) |
| 2019 | $5,429 | 4 | AstraZeneca Pharmaceuticals LP ($2,800) |
| 2018 | $644.69 | 7 | Incyte Corporation ($335.00) |
| 2017 | $36.51 | 2 | Incyte Corporation ($20.26) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2023 | Daiichi Sankyo Inc. | — | Honoraria | Cash or cash equivalent | $360.00 | General |
| 02/02/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.08 | General |
| Category: Oncology | ||||||
| 01/24/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.04 | General |
| Category: Oncology | ||||||
| 10/31/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Sickle Cell Disease | ||||||
| 10/25/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $15.85 | General |
| Category: Hematology | ||||||
| 10/06/2022 | Daiichi Sankyo Inc. | — | Honoraria | Cash or cash equivalent | $550.00 | General |
| 08/30/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Oncology | ||||||
| 04/01/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: HORMONE THERAPY | ||||||
| 09/16/2021 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Oncology | ||||||
| 11/25/2019 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 07/12/2019 | Exelixis Inc. | Cabometyx (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: Oncology | ||||||
| 07/12/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $114.49 | General |
| Category: Oncology | ||||||
| 07/12/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $64.43 | General |
| Category: Oncology | ||||||
| 11/28/2018 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $335.00 | General |
| 10/05/2018 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: BioOncology | ||||||
| 07/10/2018 | Lilly USA, LLC | — | Education | In-kind items and services | $119.18 | General |
| 04/26/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.01 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/29/2018 | Lilly USA, LLC | CYRAMZA (Drug) | Education | In-kind items and services | $125.27 | General |
| Category: Oncology | ||||||
| 03/20/2018 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Oncology | ||||||
| 01/11/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2017 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: BioOncology | ||||||
| 01/21/2017 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $20.26 | General |
About Dr. Tu Tu Aung-Hillman, M.D
Dr. Tu Tu Aung-Hillman, M.D is a Hematology & Oncology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871523001.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tu Tu Aung-Hillman, M.D has received a total of $7,153 in payments from pharmaceutical and medical device companies, with $391.12 received in 2023. These payments were reported across 22 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($3,135).
Practice Information
- Specialty Hematology & Oncology
- Location Brooklyn, NY
- Active Since 07/04/2006
- Last Updated 10/29/2015
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1871523001
Products in Payments
- Cabometyx (Drug) $2,629
- CYRAMZA (Drug) $125.27
- IMBRUVICA (Drug) $46.15
- Perjeta (Biological) $36.42
- OPDIVO (Biological) $31.12
- OXBRYTA (Drug) $20.22
- ORGOVYX (Drug) $19.75
- TAGRISSO (Drug) $16.97
- KEYTRUDA (Biological) $16.09
- Pomalyst (Drug) $15.85
- LifeVest (Device) $12.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Brooklyn
Perry Cook, M.d, M.D
Hematology & Oncology — Payments: $1.4M
Yiwu Huang, Md, MD
Hematology & Oncology — Payments: $268,275
Dr. Ilya Blokh, M.d, M.D
Hematology & Oncology — Payments: $191,276
Songchuan Guo, M.d, M.D
Hematology & Oncology — Payments: $106,907
Yiqing Xu, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $51,145
Dr. Azriel Hirschfeld, M.d, M.D
Hematology & Oncology — Payments: $48,699